Scribd
Upload
9 views1 page

Relative Valuation

The document presents a comparable company valuation for CIPLA Ltd, including market data, financials, and valuation metrics. It compares CIPLA with other pharmaceutical companies, providing key figures such as share price, equity value, enterprise value, and various valuation multiples. The analysis indicates that CIPLA is undervalued based on the implied market value per share derived from different valuation methods.

Uploaded by

Sagar Sahu
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
9 views1 page

Relative Valuation

The document presents a comparable company valuation for CIPLA Ltd, including market data, financials, and valuation metrics. It compares CIPLA with other pharmaceutical companies, providing key figures such as share price, equity value, enterprise value, and various valuation multiples. The analysis indicates that CIPLA is undervalued based on the implied market value per share derived from different valuation methods.

Uploaded by

Sagar Sahu
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Comparable Company Valuation - CIPLA LTD

CIPLA LTD.
BSE : 500087

Amount in crores
Market Data Financials Valuation
Share
Company Ticker Share Price Outstanding Equity Value Net Debt Enterprise Value Revenue EBITDA Net Income EV/Revenue EV/EBITDA P/E

Cipla CIPLA 1,378.4 80.8 1,11,431.2 (332.5) 1,11,098.8 28,349.6 8,235.9 5,433.7 3.9x 13.5x 20.5x
Sun [Link]. SUNPHARMA 1,613.8 239.9 3,87,632.7 (6,116.5) 3,81,516.2 54,964.0 18,565.4 10,484.7 6.9x 20.5x 37.0x
Divi's Lab. DIVISLAB 6,013.0 26.6 1,59,593.8 (3,625.0) 1,55,968.8 10,029.0 3,677.9 2,485.0 15.6x 42.4x 64.2x
Torrent Pharma. TORNTPOWER 3,976.8 33.8 1,34,454.8 2,242.5 1,36,697.3 12,248.0 3,943.7 2,140.0 11.2x 34.7x 62.8x
Lupin LUPIN 2,168.3 45.7 98,997.7 3,074.7 1,02,072.3 24,750.7 7,027.1 4,347.5 4.1x 14.5x 22.8x
Dr Reddy's Labs DRREDDY 1,166.7 83.5 97,438.9 3,393.8 1,00,832.7 34,310.0 9,754.0 5,737.6 2.9x 10.3x 17.0x
Zydus Lifesci. ZYDUSLIFE 873.4 100.6 87,884.5 6,679.3 94,563.8 24,493.9 8,021.9 5,029.5 3.9x 11.8x 17.5x
Mankind Pharma MANKIND 2,124.3 41.3 87,665.3 7,814.2 95,479.4 13,545.7 3,778.2 1,774.0 7.0x 25.3x 49.4x
Alkem Lab ALKEM 5,720.5 12.0 68,470.4 792.5 69,262.9 13,890.2 3,289.6 2,410.2 5.0x 21.1x 28.4x
Aurobindo Pharma ABBOTINDIA 1,141.7 58.1 66,332.9 (441.0) 65,891.9 32,514.5 7,145.2 3,420.7 2.0x 9.2x 19.4x

High 15.6x 42.4x 64.2x


75th Percentile 7.0x 24.2x 46.3x
Average 6.3x 20.3x 33.9x
Median 4.6x 17.5x 25.6x
25th Percentile 3.9x 12.2x 19.7x
Low 2.0x 9.2x 17.0x

Cipla Comparable Valuation EV/Revenue EV/EBITDA P/E

Implied Enterprise Value 1,29,139.3 1,44,439.1 1,38,715.1


Net Debt (332.5) (332.5) (332.5)
Implied Market Value 1,29,471.8 1,44,771.5 1,39,047.6
Shares Outstanding 80.8 80.8 80.8

Implied Value Per Share 1,602.8 1,792.2 1,721.3

Source: [Link]
Undervalued Undervalued Undervalued

You might also like